aTyr Pharma | LIFE - Interest Expense On Debt

Stock Price
0.81
Daily Change
-0.004 -0.49%
Monthly
-22.02%
Yearly
-78.43%
Q1 Forecast
0.82

aTyr Pharma reported 765K in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Ardelyx USD 5.76M 37K Dec/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Cipla INR 140.3M 8.5M Dec/2025
Compugen USD 954K 116K Sep/2025
CSL USD 215M 111M Dec/2025
Curis USD 178K 441K Dec/2023
Galapagos EUR 1.72M 940K Sep/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
Grifols EUR 156.07M 31.46M Sep/2025
Novartis USD 281M 8M Sep/2025
Roche Holding CHF 304M 7.5M Jun/2025
United Therapeutics USD 3.1M 100K Dec/2025
Xoma USD 3.4M 150K Jun/2024